SEC Form 4 · accession 0001213900-18-017963
IMMUCELL CORP /DE/ · ICCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Brigham
Officer — President & CEO · Director
Period of report
Dec 28, 2018
Accepted (ET)
Dec 28, 2018 · 1:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.10 per share | Dec 28, 2018 | M | 47,500 | $1.70 | A | 204,752 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Options (Right to buy) | $1.70 | Dec 28, 2018 | M | 47,500 | D | Jan 9, 2012 | Jan 8, 2019 | Common Stock | 47,500 | 0 | D |